Nymox Pharm Corp (NYMXF)

$0.00 0.00 (N/A)
Market Cap 19,000.00
Revenue (ttm) 0.00
Net Income (ttm) -4.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 100
Avg Vol 40,072
Day's Range N/A - N/A
Shares Out 94.54M
Stochastic %K 0%
Beta 13.85
Analysts Strong Buy
Price Target N/A

Company Profile

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert, a test for determining smoking status; and TobacAlert, a test for detecting second-hand smoke exposure. In addition, it develops drugs for...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 936 9669
Fax: 514 332 2227
Website: nymox.com
Address:
Bay & Deveaux Streets, 2nd Floor, Nassau, Bahamas
usa2018
usa2018 Sep. 1 at 1:29 PM
$NYMXF This is so exciting. Dr A has 43,133,010 shares and Director Morse has 245,596 for a total of 43,378,406 shares based on the last annual report that was filed a long time ago. Those 43,378,406 shares represented 92% of the 47,066,029 votes in favor of continuing down the same path. It pays to double dip Salary and Stock for situations like this. I’m sure the next 100 share block that trades at .0002 is probably the head of the FDA getting in before the Application is refiled. Let the Fraud continue.
2 · Reply
svseeker3000
svseeker3000 Sep. 1 at 12:48 PM
$NYMXF From Edgar..... https://www.sec.gov/Archives/edgar/data/1018735/000164033426001427/nymox_6k.htm
0 · Reply
IPGreen
IPGreen Aug. 31 at 9:42 PM
$NYMXF looks like the new slate of directors received over a 98% approval. Hopefully better things are in our future
0 · Reply
usa2018
usa2018 Aug. 31 at 1:45 PM
$NYMXF In the short term the only way for Nymox to be successful is a Buy Out. We are told Nymox has Great Leadership with Dr A, a new exciting Board and a great Drug that apparently the 8 Jurisdictions that Rejected it just don’t understand. The current stock price is .0002 cents per share. If Big Pharma paid 3 times the current stock price which would be .0006 cents and if there are 100 million shares the buyout would be $60,000! Why are there no offers to buy Nymox for $60,000, a premium of only 3 times current stock price? Why???????????????
1 · Reply
usa2018
usa2018 Aug. 28 at 3:27 PM
$NYMXF WOW.....Nymox stock price is back down to .0002! I'm getting the feeling investors don't think the company is going to be successful. I keep hearing nothing to worry about, can the Dr A Loyalists and new Board Members update us on the future?
1 · Reply
usa2018
usa2018 Aug. 25 at 5:45 PM
$NYMXF big price move. From.0002 to .0003. Could it go to .0004 tomorrow
1 · Reply
usa2018
usa2018 Aug. 14 at 2:55 PM
$NYMXF 110 shares have traded at .0002. Looks like the New Board Members are starting to load up. The question is will they be selling when the stock price rockets up to .002?
1 · Reply
usa2018
usa2018 Aug. 12 at 1:42 PM
$NYMXF His name is on the SEC Filing to be a Director of Nymox. Looks like Passeraser a frequent poster on this Board supporting Dr A and the way he has managed Nymox will be joining the Board of Directors. If the new Board Members which average 73 years in age like the way Dr A manages Nymox I would think the direction Nymox has taken over the past 3 years will accelerate. Can the stock price possibly get lower to possibly .0000002 from .0002? On the Proxy Card checking “Withhold” as a vote choice looks like a great option.
1 · Reply
IPGreen
IPGreen Aug. 11 at 3:28 PM
$NYMXF other than the loss of Mr Robinson, it looks like we are really upgrading our BOD
2 · Reply
usa2018
usa2018 Aug. 11 at 2:44 PM
$NYMXF Dr a has mis-managed Nymox and the Drug Development in deviating from the FDA instructions and most likely altering the Data so even Dr Claus Roehrborn could not figure it out. The result 8 REJECTIONS, a stock price of 2-10,000th of a penny, (0002) but a boat load of Loyalists, probably his family, who still honor and love him. So, with new Board Members desperately needed you’d think Dr A would find a well-known Urologist to join the Leadership Team and lead the way. Nope, Dr A finds a Veterinarian! Dr Kresimir Pucaj, DVM a 73-year-old Canadian Veterinarian to lead the Medical Process with the FDA and the other Jurisdictions that have issued Rejections. Is Dr A joking? There has been no approval for the Drug in Humans, so it looks like Dr A is he now pivoting to animals? I’m now waiting for the SPCA to issue a Refuse To File so as to save all animals.
1 · Reply
Latest News on NYMXF
No data available.
usa2018
usa2018 Sep. 1 at 1:29 PM
$NYMXF This is so exciting. Dr A has 43,133,010 shares and Director Morse has 245,596 for a total of 43,378,406 shares based on the last annual report that was filed a long time ago. Those 43,378,406 shares represented 92% of the 47,066,029 votes in favor of continuing down the same path. It pays to double dip Salary and Stock for situations like this. I’m sure the next 100 share block that trades at .0002 is probably the head of the FDA getting in before the Application is refiled. Let the Fraud continue.
2 · Reply
svseeker3000
svseeker3000 Sep. 1 at 12:48 PM
$NYMXF From Edgar..... https://www.sec.gov/Archives/edgar/data/1018735/000164033426001427/nymox_6k.htm
0 · Reply
IPGreen
IPGreen Aug. 31 at 9:42 PM
$NYMXF looks like the new slate of directors received over a 98% approval. Hopefully better things are in our future
0 · Reply
usa2018
usa2018 Aug. 31 at 1:45 PM
$NYMXF In the short term the only way for Nymox to be successful is a Buy Out. We are told Nymox has Great Leadership with Dr A, a new exciting Board and a great Drug that apparently the 8 Jurisdictions that Rejected it just don’t understand. The current stock price is .0002 cents per share. If Big Pharma paid 3 times the current stock price which would be .0006 cents and if there are 100 million shares the buyout would be $60,000! Why are there no offers to buy Nymox for $60,000, a premium of only 3 times current stock price? Why???????????????
1 · Reply
usa2018
usa2018 Aug. 28 at 3:27 PM
$NYMXF WOW.....Nymox stock price is back down to .0002! I'm getting the feeling investors don't think the company is going to be successful. I keep hearing nothing to worry about, can the Dr A Loyalists and new Board Members update us on the future?
1 · Reply
usa2018
usa2018 Aug. 25 at 5:45 PM
$NYMXF big price move. From.0002 to .0003. Could it go to .0004 tomorrow
1 · Reply
usa2018
usa2018 Aug. 14 at 2:55 PM
$NYMXF 110 shares have traded at .0002. Looks like the New Board Members are starting to load up. The question is will they be selling when the stock price rockets up to .002?
1 · Reply
usa2018
usa2018 Aug. 12 at 1:42 PM
$NYMXF His name is on the SEC Filing to be a Director of Nymox. Looks like Passeraser a frequent poster on this Board supporting Dr A and the way he has managed Nymox will be joining the Board of Directors. If the new Board Members which average 73 years in age like the way Dr A manages Nymox I would think the direction Nymox has taken over the past 3 years will accelerate. Can the stock price possibly get lower to possibly .0000002 from .0002? On the Proxy Card checking “Withhold” as a vote choice looks like a great option.
1 · Reply
IPGreen
IPGreen Aug. 11 at 3:28 PM
$NYMXF other than the loss of Mr Robinson, it looks like we are really upgrading our BOD
2 · Reply
usa2018
usa2018 Aug. 11 at 2:44 PM
$NYMXF Dr a has mis-managed Nymox and the Drug Development in deviating from the FDA instructions and most likely altering the Data so even Dr Claus Roehrborn could not figure it out. The result 8 REJECTIONS, a stock price of 2-10,000th of a penny, (0002) but a boat load of Loyalists, probably his family, who still honor and love him. So, with new Board Members desperately needed you’d think Dr A would find a well-known Urologist to join the Leadership Team and lead the way. Nope, Dr A finds a Veterinarian! Dr Kresimir Pucaj, DVM a 73-year-old Canadian Veterinarian to lead the Medical Process with the FDA and the other Jurisdictions that have issued Rejections. Is Dr A joking? There has been no approval for the Drug in Humans, so it looks like Dr A is he now pivoting to animals? I’m now waiting for the SPCA to issue a Refuse To File so as to save all animals.
1 · Reply
svseeker3000
svseeker3000 Aug. 8 at 9:38 PM
$NYMXF https://www.sec.gov/Archives/edgar/data/1018735/000164033426001291/nymox_6k.htm
0 · Reply
itaintwhatyou
itaintwhatyou Aug. 8 at 11:33 AM
$NYMXF See new 6K / BOD meeting to elect new Directors
0 · Reply
usa2018
usa2018 Aug. 7 at 3:16 PM
$NYMXF Big news. I’m now hearing the Nymox share price drop to .0002 was the result of the Application for Approval that was submitted to Gilligan’s Island. The Professor wrote that even though The Skipper and Gilligan both got The Shot in their ass, the submission by Dr A for Approval was incomplete, poorly organized, or lacked critical safety, efficacy, or quality data. This is from the Professor who sure is not as knowledgeable as the FDA Experts. Can anybody think of a deserted island or 3rd World County that might give and approval like Roatan Island did? We need to get the stock price up to at least .002! But don't worry everything is ok with Nymox and Dr A......
0 · Reply
usa2018
usa2018 Aug. 7 at 12:57 PM
$NYMXF at a stock price of .0002 does anybody know how many shares it will take to convert the Loan Payables to Stock Shares? Will the Dilution be a negative for Dr A's Company?
0 · Reply
usa2018
usa2018 Aug. 6 at 3:26 PM
$NYMXF The OTC Markets Web Site is reporting last trade of 1,101 shares of Nymox was at .0002. That’s a total value of .2202 cents. The Dr A Loyalists fought off that Ascella deal so they cold get a better price. That price is here so LOAD UP at this great price, .0002 You’re welcome
1 · Reply
usa2018
usa2018 Aug. 5 at 6:31 PM
$NYMXF I'm constantly told things are good with Nymox, Dr A and there is nothing to worry about. So maybe I should believe in Miracles too! Do you think the 400 shares traded today was Roche, J&J or some other Big Pharma getting a position to start a merger? So exciting.......
1 · Reply
IPGreen
IPGreen Jul. 28 at 6:40 PM
$NYMXF I wonder if that volume is one transaction
0 · Reply
usa2018
usa2018 Jul. 24 at 5:40 PM
$NYMXF I'm expecting Legal Action by Shareholders againest the Dr A, His Estate, along with The Mark's , Director Robinson, Estate for huge damages due to the Fraud of Dr A. causing the Loss of Value especially when Ascella was going to save the Company till Dr A caused the distraction. That's where the deep pockets are so get ready to sign on to a Class Action Suit and recoup some of the losses. We will get some money back!
4 · Reply
usa2018
usa2018 Jul. 24 at 12:39 PM
$NYMXF We finally showed Ascella who is in charge and who has the best business skills. Lets take a big bow that we pushed back on the Restore Group and the Ascella Proposal of 2023. Imagine Ascella having the nerve to think we would jump at their offer of putting Millions of Dollars in with no recourse to redo the Trials to FDA Standards. They are just Pathetic. So Thankful we have Dr A and Very Loyal Shareholders who knew Dr A could lead the Company to the Finish Line. Nymox now trading on the Lowest Tier Expert OTC Exchange and trading at a Half a Cent or Lower I think we made the Finish Line. HIP HIP HOORAY….HIP HIT HOORAY FOR Dr A and THE LOYAL SHAREHOLDERS WHO GOT US HERE…..HIP HIP HORRAY
0 · Reply
HFH_Inc
HFH_Inc Jul. 23 at 5:25 PM
$NYMXF This is one Zimbabwe approval away from reaching one penny per share. It's coming. Exciting times in here!
0 · Reply
usa2018
usa2018 Jul. 22 at 12:56 PM
$NYMXF Now that Nymox last trade was for .005, a half a cent, here is photo. There are 2 things missing from this photo. 1. Dr A inside 2. Door closed and locked.
0 · Reply
giannobes14
giannobes14 Jul. 21 at 9:45 PM
$NYMXF any other news after June 2, other than USA's posts?
2 · Reply